Biofidus

Executive Summary

Biofidus AG is a German contract research organization (CRO) that provides comprehensive bioanalytical services for biologics and small molecules, from discovery through commercialization. Founded in 2018 and based in Munich, the company leverages state-of-the-art mass spectrometry, chromatography, cell-based assays, and sequencing to support pharmaceutical and biotech clients. By offering a holistic platform for structural and functional characterization, Biofidus addresses complex analytical challenges with speed and reliability. As part of the diagnostics, AI/machine learning, and proteomics sectors, it is well-positioned to benefit from the growing outsourcing trends in biopharma R&D. Although private and without disclosed funding, the company’s focus on cutting-edge technologies and its strategic location in a key European biotech hub suggest potential for steady growth. However, the CRO market is competitive, and its limited scale may constrain revenue expansion.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-driven proteomics analysis platform65% success